Our working hypothesis is that patients developing metastasis exhibit a tumor micro-environment characterized by altered estrogen and hypoxia signaling that activates the H19/cell adhesion molecules circuitry, governing the metastatic program toward a collective cancer cell migration. The gene discussed is H19; the disease is neoplasm.